Related Experiment Video
Updated: Feb 11, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Transplant Drug Interactions and a Word of Caution for the HIV Provider. A Case Report
Marion Hemmersbach-Miller1, Carl L Berg2, Julia A Messina1
1Division of Infectious Diseases, Durham, North Carolina.
Abstract:
Electronic medical record platforms fail to support provider alerts when a drug is discontinued. Protease inhibitors, often boosted by ritonavir or cobicistat, increase the serum concentration of calcineurin inhibitors. This case demonstrates acute liver transplant rejection in an HIV-positive recipient due to a failure to recognize the loss of protease inhibitor interaction with his immunosuppressive regimen.
More Related Videos
Related Concept Videos
Data Reporting and Recording
Pharmacokinetics: Drug–Drug Interactions
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...

